The Department of Defense (DoD) is offering the Neurofibromatosis Investigator-Initiated Focused Research Award to support investigator-initiated studies on Neurofibromatosis (NF) and/or Schwannomatosis. This grant is for research addressing key areas such as pain, wound repair, nerve regeneration, stress and inflammation, cognitive dysfunction, health-related quality of life, and the neurofibromin protein. While human subject research is permitted, clinical trials are explicitly not allowed. Applicants must submit relevant preliminary data. The DoD highly encourages collaborative research between basic and clinical scientists or industry partners, offering higher funding for projects where qualified collaborators significantly contribute to the proposed work and bring new perspectives.
Opportunity ID: 52050
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-NFRP-IIFRA |
| Funding Opportunity Title: | DoD Neurofibromatosis Investigator-Initiated Focused Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 23, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 20, 2010 |
| Current Closing Date for Applications: | May 20, 2010 |
| Archive Date: | Jun 19, 2010 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Investigator-Initiated Focused Research Award (IIFRA) mechanism is being offered for the first time in FY10. Research Focus Areas: Proposals for this mechanism must address one or more of the following areas related to NF and/or Schwannomatosis: Pain Wound repair Nerve regeneration Stress and inflammation Cognitive dysfunction Health-related quality of life Neurofibromin protein Research involving participation of human subject use is permitted; however, clinical trials are NOT ALLOWED under this funding opportunity. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. Applications must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project. Optional Qualified Collaborator(s): The FY10 NFRP strongly encourages collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the NF field are also strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding as described in Section I.D. For the application to qualify for the higher level of funding, the PI must submit a Statement of Collaboration that clearly identifies the collaborating investigator and addresses how each of the criteria below are met. Additionally, the collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear that the success of the project depends on the unique skills and contributions of each partner. The collaborator(s) must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. ○ A proposed project in which the collaborator(s) merely supplies tissue samples or access to patients will not meet the intent and will not be qualified for the higher level of funding. The collaborator(s) must be at or above the level of Assistant Professor (or equivalent). At least a 10% level of effort is required of the collaborator(s). Contribution of the collaborator should be reflected in the applications budget. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 52050 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 52050 Full Announcement-1 -> nfrp_fy10 iifra pa_gg.pdf
Folder 52050 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00016608 | Feb 23, 2010 | May 20, 2010 | View |
Package 1
Mandatory forms
52050 RR_SF424_1_2-1.2.pdf
52050 PerformanceSite_1_4-1.4.pdf
52050 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
